VERONA PHARMA PLC - AM
74.23
21-May-25 09:50:41
15 minutes delayed
Stocks
-0.51
-0.68%
Today's range
74.11 - 75.60
ISIN
N/A
Source
NASDAQ
-
15 Aug 2022 13:05:00 By Nasdaq GlobeNewswire
-
Verona Pharma plc Announces Pricing of Upsized Underwritten Public Offering
10 Aug 2022 17:22:20 By Nasdaq GlobeNewswire
-
Verona Pharma plc Announces Proposed Underwritten Public Offering
09 Aug 2022 13:16:44 By Nasdaq GlobeNewswire
-
Verona Pharma Reports Second Quarter 2022 Financial Results and Provides Corporate Update
09 Aug 2022 00:01:03 By Nasdaq GlobeNewswire
-
Verona Pharma Announces Ensifentrine Meets Primary Endpoint in Phase 3 ENHANCE-2 Trial for COPD
08 Aug 2022 23:00:00 By Nasdaq GlobeNewswire
-
08 Aug 2022 13:30:00 By Nasdaq GlobeNewswire
-
Verona Pharma to Report Second Quarter 2022 Financial Results and Provide Corporate Update
28 Jul 2022 23:00:00 By Nasdaq GlobeNewswire
-
08 Jun 2022 23:00:00 By Nasdaq GlobeNewswire
-
Verona Pharma to Host KOL Event on June 16, 2022
05 Jun 2022 23:00:00 By Nasdaq GlobeNewswire
-
Verona Pharma to Present at Jefferies Healthcare Conference
24 May 2022 23:00:00 By Nasdaq GlobeNewswire
-
08 May 2022 23:00:00 By Nasdaq GlobeNewswire
-
Verona Pharma Announces May 2022 Investor Conference Participation
03 May 2022 23:00:00 By Nasdaq GlobeNewswire
-
Verona Pharma Reports First Quarter 2022 Financial Results and Provides Corporate Update
02 May 2022 23:00:00 By Nasdaq GlobeNewswire
-
Verona Pharma to Report First Quarter 2022 Financial Results and Provide Corporate Update
18 Apr 2022 23:00:00 By Nasdaq GlobeNewswire
-
James Brady Joins Verona Pharma as Non-Executive Director
14 Mar 2022 00:00:00 By Nasdaq GlobeNewswire
-
02 Mar 2022 23:00:00 By Nasdaq GlobeNewswire
-
16 Feb 2022 23:00:00 By Nasdaq GlobeNewswire
-
23 Jan 2022 23:00:00 By Nasdaq GlobeNewswire
-
Verona Pharma Completes Enrollment in ENHANCE-1 48-week Subset
04 Jan 2022 23:00:00 By Nasdaq GlobeNewswire
-
Verona Pharma to Present at H.C. Wainwright BioConnect Virtual Conference
03 Jan 2022 23:00:00 By Nasdaq GlobeNewswire